Cargando…
Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth
The nuclear receptor-binding SET domain 3 (NSD3) catalyzes methylation of histone H3 at lysine 36 (H3K36), and promotes malignant transformation and progression of human cancer. Its expression, potential functions and underlying mechanisms in pancreatic cancer are studied. Bioinformatics studies and...
Autores principales: | Sun, Yihui, Xie, Jiaming, Cai, Shang, Wang, Qian, Feng, Zhenyu, Li, Yecheng, Lu, Jing-jing, Chen, Wei, Ye, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494902/ https://www.ncbi.nlm.nih.gov/pubmed/34615858 http://dx.doi.org/10.1038/s41419-021-04205-6 |
Ejemplares similares
-
Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in Pancreatic Cancer
por: Ye, Zhenyu, et al.
Publicado: (2020) -
Transplantation of splenic tissue after splenectomy: A case report
por: Ma, Xiaoming, et al.
Publicado: (2022) -
Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)
por: Li, Yecheng, et al.
Publicado: (2021) -
Integrated bioinformatics identifies the dysregulation induced by aberrant gene methylation in colorectal carcinoma
por: Ye, Zhenyu, et al.
Publicado: (2020) -
NSD3, a member of nuclear receptor‐binding SET domain family, is a potential prognostic biomarker for pancreatic cancer
por: Xiong, Qunli, et al.
Publicado: (2023)